IIQ · ASX

Inoviq Ltd (ASX:IIQ)

AU$0.52

 -0.005 (-0.952%)
ASX:Live
20/12/2024 03:46:23 PM
HALO Ords HALO Consensus Value GROWTH AUS EMA 125 Breakup All-Consensus +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IIQ Overview

IIQ Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About IIQ

Website

Inoviq Ltd

Telephone

61.3.9548.7586

Address

23 Normanby Road Notting Hill, Victoria (VIC) 3168

Description

INOVIQ Ltd. is a biotechnology company, which engages in the provision of medical services. It operates through the Australia and United States of America geographical segments. The company was founded on June 30, 1983 and is headquartered in Notting Hill, Australia.

IIQ Price Chart

Key Stats

Market Cap

AU$59.67M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.42 - 0.92

Trade Value (12mth)

AU$18,422.00

1 week

0%

1 month

15.38%

YTD

-22.22%

1 year

-20.45%

All time high

61.12

Key Fundamentals

EPS 3 yr Growth

-50.90%

EBITDA Margin

%

Operating Cashflow

-$4m

Free Cash Flow Return

-21.50%

ROIC

-32.70%

Interest Coverage

-155.80

Quick Ratio

7.10

Other Data

Shares on Issue (Fully Dilluted)

92m

HALO Sector

Healthcare

Next Company Report Date

02-Sep-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

IIQ Announcements

Latest Announcements

Date Announcements

16 December 24

Weaponising Exosomes for Breast Cancer treatment

×

Weaponising Exosomes for Breast Cancer treatment

11 December 24

Investor Webinar Presentation

×

Investor Webinar Presentation

05 December 24

Disease Specificity study completed for NeuCA15-3 test

×

Disease Specificity study completed for NeuCA15-3 test

03 December 24

EXO-OC test delivers outstanding performance

×

EXO-OC test delivers outstanding performance

02 December 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

02 December 24

AGM Replay

×

AGM Replay

29 November 24

Notification regarding unquoted securities - IIQ

×

Notification regarding unquoted securities - IIQ

28 November 24

AGM CEO Presentation

×

AGM CEO Presentation

28 November 24

2024 AGM Results of Meeting

×

2024 AGM Results of Meeting

26 November 24

INOVIQ receives $1m RDTI refund

×

INOVIQ receives $1m RDTI refund

31 October 24

Quarterly Business Update and Appendix 4C - September 2024

×

Quarterly Business Update and Appendix 4C - September 2024

25 October 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

09 October 24

Application for quotation of securities - IIQ

×

Application for quotation of securities - IIQ

09 October 24

Cleansing Notice

×

Cleansing Notice

01 October 24

Notification of cessation of securities - IIQ

×

Notification of cessation of securities - IIQ

01 October 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

01 October 24

Initial Director's Interest Notice

×

Initial Director's Interest Notice

26 September 24

Board Nomination Closing Date

×

Board Nomination Closing Date

20 September 24

2024 Annual Report

×

2024 Annual Report

17 September 24

Becoming a substantial holder

×

Becoming a substantial holder

17 September 24

Change in substantial holding

×

Change in substantial holding

06 September 24

Application for quotation of securities - IIQ

×

Application for quotation of securities - IIQ

06 September 24

Cleansing Notice

×

Cleansing Notice

05 September 24

Proposed issue of securities - IIQ

×

Proposed issue of securities - IIQ

03 September 24

Mary Harney - Non-Executive Director

×

Mary Harney - Non-Executive Director

IIQ Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.20 -0.10 -0.07 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.20 -0.10 -0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock -38.8 51.3 27.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.05 -0.08 -0.05 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.07 -0.08 -0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock 11.5 -44.1 40.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock -17.9 -9.3 -8.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.31 0.21 0.22 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.18 0.10 0.11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 397.0 -46.1 14.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 91 92 92 Lock Lock Lock
Basic m Lock Lock Lock Lock 91 92 92 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -40.9 43.9 34.4 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 7 9 7 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -2 -1 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 45.4 44.7 4.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -679.8 -261.2 -185.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 780 361 285 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -7 -9 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -10.5 -28.2 29.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2,542.3 -2,265.9 -1,187.2 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 2 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -9 -10 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -25.5 -14.0 25.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3,301.7 -2,615.9 -1,457.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -22 -10 -8 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -3 -1 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -18 -9 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -63.2 50.7 26.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -6,575.0 -2,252.5 -1,224.8 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -6 -7 -4 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 17 0 6 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -6 -7 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -11.7 -15.0 38.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -22.9 -18.3 -8.4 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 15 8 9 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 31 22 22 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -14 -7 -9 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 2 2 2 Lock Lock Lock
Equity $m Lock Lock Lock Lock 28 20 20 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 29 20 20 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3.5 -30.9 0.8 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -59.1 -41.7 -30.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -64.3 -45.7 -32.8 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -30.7 -42.0 -38.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -61.8 -36.7 -32.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -20.6 -28.7 -21.5 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -85.8 -151.6 -155.8 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.0 0.8 1.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -50.9 -36.1 -43.5 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 9.7 6.2 7.1 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 9.7 6.2 7.1 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 88.1 83.1 85.0 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -337.5 -462.8 -281.7 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.3 0.3 0.4 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 70.8 92.1 85.6 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.1 0.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 368.5 117.3 117.1 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -7,794.5 -2,527.4 -1,416.7 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -70.1 -46.8 -34.9 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -59.1 -41.7 -30.2 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.1 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -64.3 -45.7 -32.8 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -64.3 -45.7 -32.8 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 5.2 4.0 4.3 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 1,269.7 1,328.6 841.4 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 1,274.9 1,332.6 845.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 139.6 188.1 130.9 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 1,135.3 1,144.5 714.8 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IIQ Shortsell

Frequently Asked Questions

The current share price of Inoviq Ltd (IIQ:ASX) is AU$0.52.
The 52-week high share price for Inoviq Ltd (IIQ:ASX) is AU$0.92.
The 52-week low share price for Inoviq Ltd (IIQ:ASX)? is AU$0.42.
Inoviq Ltd (IIQ:ASX) does not pay a dividend.
Inoviq Ltd (IIQ:ASX) does not pay a dividend.
Inoviq Ltd (IIQ:ASX) has a franking level of 0.0%.
Inoviq Ltd (IIQ:ASX) is classified in the Healthcare.
The current P/E ratio for Inoviq Ltd (IIQ:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.